No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year: original Article

Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway.
Journal of Internal Medicine (Impact Factor: 5.79). 10/2009; 267(5):462-72. DOI: 10.1111/j.1365-2796.2009.02181.x
Source: PubMed

ABSTRACT Cross-sectional studies indicate vitamin D to be of importance for glucose tolerance, blood pressure and serum lipids, but whether supplementation with vitamin D would improve cardio-vascular risk factors is not known.
The study was a 1 year, double blind placebo-controlled intervention trial performed at the University Hospital of North Norway from November 2005 to October 2007. Subjects. A total of 438 overweight or obese subjects, 21-70 years old, were included and 330 completed the study.
The subjects were randomized to vitamin D (cholecalciferol, vitamin D(3)) 40 000 IU per week (DD group), vitamin D 20 000 IU per week (DP group), or placebo (PP group). All subjects were given 500 mg calcium daily.
Fasting serum lipids and blood pressure were measured and an oral glucose tolerance test performed at start and end of the study.
At baseline the mean serum 25(OH)D levels were 58 nmol L(-1) (all subjects) and increased to 140 and 101 nmol L(-1) in the DD and DP groups, respectively. No significant differences were found between the three groups regarding change in measures of glucose metabolism or serum lipids. In the DP group, there was a slight but significant increase in systolic blood pressure compared with the placebo group.
Our results do not support a positive effect of vitamin D on glucose tolerance, blood pressure or serum lipids. Further studies in subjects with low serum 25(OH)D levels combined with impaired glucose tolerance, hypertension or dyslipidaemia are needed.

Download full-text


Available from: Monica Sneve, Jun 02, 2015
  • Source
    • "(OH) 2 D, which has been associated with an increase in lipogenesis and lipolysis [28]. We found a positive but non-significant association between high-density lipoprotein levels and supplementation with vitamin D. Other randomized clinical trials had similar findings [23] [24] [26], with differences in the mean concentrations of HDL slightly lower to 3 [24], or close to 1 mg/dL [23]. However, there are studies of this relationship generated discordant findings [28] [29]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background & aims Dyslipidemia is a risk factor for cardiovascular disease that has become an increasing public health problem. Dyslipidemia is especially relevant in vulnerable populations such as postmenopausal women. Low serum levels of 25-hydroxyvitamin D have been associated with an unfavourable lipid profile. Due to contradictory findings from intervention trials, we investigated the effect of vitamin D supplementation on serum lipids in postmenopausal women with type 2 diabetes. Methods One hundred and four postmenopausal women with type 2 diabetes were randomly assigned in a double-blind manner to 1 of 2 groups taking a daily tablet for 6 months: a group consuming 4000 IU tablets of a vitamin D supplement (vitamin D group n = 52) or a group consuming placebo tablets (placebo group n = 52). Results Ninety nine percent of participants completed the trial. In the vitamin D group mean serum levels of 25(OH)D3 improved significantly at the end of the follow-up period (+25.5 nmol/L; P = <0.001). Intention-to-treat analysis revealed no significant changes in low density lipoproteins, high density lipoproteins and total cholesterol concentrations, but did identify a greater decrease in serum triglycerides in the vitamin D group. The average effect of supplementation on the treated group was −34.24 mg/dL (P = 0.021), while the average treatment effect was −31.8 mg/dL (P = 0.023). Conclusions Our results suggest that supplementation with vitamin D (4000 IU/d) may have a beneficial effect on serum triglyceride levels without otherwise affecting levels of other lipids. This trial was registered at as NCT01019642.
    Clinical Nutrition 10/2014; DOI:10.1016/j.clnu.2014.10.002 · 3.94 Impact Factor
  • Source
    • "Indeed, bariatric surgical procedures may induce malabsorption; therefore, the combination of both low preoperative vitamin concentration and malabsorption may render these patients more prone to severe vitamin D deficiencies. Supplementation with vitamin D should be considered before and after surgery [71]. In any case, clinical studies to determine optimal treatment guidelines for the surgical and nonsurgical population with obesity are warranted. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The skin synthesis of vitamin D represents the first step of a metabolic pathway whose features have been extensively studied and clarified in the last decades. In particular, the production of active and inactive forms of the hormone and the actions of the corresponding enzymes have offered new insights into the knowledge of vitamin D metabolism. Additionally, the description of the different organs and tissues expressing the vitamin D receptor and its possible functions, as well as its genetic determinants, have allowed focusing on the interrelationship between vitamin D and many physiological and pathological functions. In this context, many studies reported the association between vitamin D and adipose tissue metabolism, as well as the possible role of the hormone in obesity, weight, and fat mass distribution. Finally, many reports focused on the vitamin D-related effects on skeletal muscle, particularly on the mechanisms by which vitamin D could directly affect muscle mass and strength. This paper is mainly aimed to review vitamin D metabolism and its relationship with obesity and skeletal muscle function.
    International Journal of Endocrinology 08/2014; 2014:841248. DOI:10.1155/2014/841248 · 1.52 Impact Factor
  • Source
    • "nswer the question of potential differences between short - versus long - term effects of normal and high dose vitamin D supplementation on blood pressure , vascular function , and cardiovascular outcome ( Forman et al . , 2005 ) . Vitamin D supplementation as an effective strategy to lower blood pressure and prevent hypertension remains unclear . Jorde et al . ( 2010 ) indicated that clinical study should have sufficient statistical power to examine whether high - dose , long - term vitamin D supplementation can reduce the incidence of hypertension or not . Majority of the clinical trials reported that lower levels of vitamin D may be related with higher blood pressure and higher risk of developing "
    [Show abstract] [Hide abstract]
    ABSTRACT: Vitamin D supplementation appears to be potential for reducing risks of cancer, cardiovascular disease, and other chronic diseases, existing evidence on its benefits and risks is inadequate and debatable. Questions remain as to whether supplementation of Vitamin D playing any role in the above mentioned diseases. In the absence of compelling evidence for benefit, taking supplement is producing any risk or not. While sorting the various positive and negative claims for Vitamin D, it attracts an urgent need for further research and review on reports to answer fundamental questions about the risks and benefits of supplementation. There still remains a great need to advance our understanding regarding the effectiveness of Vitamin D. This review gives an overview on disputes of Vitamin D supplementation that is convincing and interventional regarding burning issues of Vitamin D therapy. Beyond its use to prevent osteomalacia or rickets, the evidence for other health effects of vitamin D supplementation in the general inhabitants is conflicting. It is a well known predictability that any effective substance also has unwanted side effects, so clear cut evidence regarding the safety is required before supplementing Vitamin D for pathological conditions and other health benefits.
    International Food Research Journal 01/2014; 21(6):2075-2081.